Logo

American Heart Association

  1
  0


Final ID: TP272

Transthoracic Echocardiographic Findings in Cryptogenic stroke: Prevalence and Comparisons to other Subtypes of Ischemic Stroke

Abstract Body: Background: Certain findings on transthoracic echocardiography (TTE) are associated with a recognized cardioembolic stroke mechanism but less is known about the prevalence of those findings in other subtypes, especially cryptogenic stroke patients. We sought to describe the prevalence of these abnormalities reported on TTE in stroke patients in a large, population-based stroke study and compare the findings specifically of cryptogenic stroke patients to those with the other identified subtypes.

Methods: In 2015, the Greater Cincinnati/Northern Kentucky Stroke Study identified all stroke cases in the 5-county area surrounding Cincinnati by ICD 9/10 codes. Potential cases were abstracted by trained study nurses and physician adjudicated, which included assigning ischemic stroke etiology based on our epidemiologic criteria. TTE reports were reviewed. Demographic information, medical history, stroke subtype and prespecified TTE features were collected for each patient and compared across stroke subtype groups. We performed a pair-wise post hoc comparison to the cryptogenic group if a difference was found amongst the groups based on the omnibus test.

Results: In 2015, there were 2481 ischemic strokes among patients 18 years or older in our 5-county area. Of these, 677 (27%) were cardioembolic, 312 (13%) large artery atherosclerotic (LAA), 419 (17%) small vessel, 154 (6%) other etiology and 919 (37%) cryptogenic. Of these ischemic stroke events, there were 1503 (61%) with TTE reports available. The severity for diastolic dysfunction, left atrial (LA) dilation, left ventricular hypertrophy and valvular abnormalities were not included in the data analysis. Cardioembolic strokes had significantly higher proportions of LA dilation, mitral and aortic regurgitation, greater LA size and area, and lower left ventricular ejection fraction (LVEF) compared to cryptogenic patients. LAA patients had a higher LA size and lower LVEF compared to cryptogenic patients. The only difference found between cryptogenic and small vessel patients was higher LA size in the latter group.

Conclusion: In a large population-based study, TTE findings in cryptogenic stroke patients were less similar to cardioembolic stroke and more similar to other subtypes. While our findings suggest it is less likely to have echocardiographic findings concerning for cardioembolic stroke in the cryptogenic population, further studies on novel and comprehensive cardiac markers are needed to confirm this.
  • Nabavizadeh, Pooneh  ( University of Cincinnati , Cincinnati , Ohio , United States )
  • Demel, Stacie  ( University of Cincinnati , Cincinnati , Ohio , United States )
  • Coleman, Elisheva  ( university of Chicago , Chicago , Illinois , United States )
  • Jasne, Adam  ( Yale Stroke Center , New Haven , Connecticut , United States )
  • Slavin, Sabreena  ( niversity of Kansas Medical Center , Kansas City , Kansas , United States )
  • Walsh, Kyle  ( UNIVERSITY OF CINCINNATI , Villa Hills , Kentucky , United States )
  • Star, Michael  ( Soroka Medical Center/Ben Gurion University , Be'er Sheva , Israel )
  • Haverbusch, Mary  ( University of Cincinnati , Cincinnati , Ohio , United States )
  • Woo, Daniel  ( NEUROLOGY DEPARTMENT , Cincinnati , Ohio , United States )
  • Robinson, David  ( University of Cincinnati , Cincinnati , Ohio , United States )
  • Khatrip, Pooja  ( University of Cincinnati , Cincinnati , Ohio , United States )
  • Stanton, Robert  ( University of Cincinnati , Cincinnati , Ohio , United States )
  • Kissela, Brett  ( University of Cincinnati , Cincinnati , Ohio , United States )
  • Kleindorfer, Dawn  ( Michigan Medicine , Ann Arbor , Michigan , United States )
  • Sucharew, Heidi  ( University of Cincinnati , Cincinnati , Ohio , United States )
  • Merkler, Alexander  ( Feil Family Brain & Mind Res Inst , New York , New York , United States )
  • Sharma, Richa  ( Yale School of Medicine , Hamden , Connecticut , United States )
  • De Los Rios La Rosa, Felipe  ( University of Cincinnati , Cincinnati , Ohio , United States )
  • Mackey, Jason  ( Indiana University , Indianapolis , Indiana , United States )
  • Ferioli, Simona  ( UNIVERSITY OF CINICNNATI , Cincinnati , Ohio , United States )
  • Mistry, Eva  ( University of Cincinnati , Cincinnati , Ohio , United States )
  • Author Disclosures:
    Pooneh Nabavizadeh: DO NOT have relevant financial relationships | Stacie Demel: No Answer | Elisheva Coleman: No Answer | Adam Jasne: DO NOT have relevant financial relationships | Sabreena Slavin: DO NOT have relevant financial relationships | Kyle Walsh: DO have relevant financial relationships ; Speaker:AstraZeneca:Past (completed) ; Researcher:Sense Diagnostics LLC:Active (exists now) ; Researcher:Jan Medical Inc.:Active (exists now) | Michael Star: DO NOT have relevant financial relationships | Mary Haverbusch: No Answer | Daniel Woo: No Answer | David Robinson: DO NOT have relevant financial relationships | Pooja Khatrip: No Answer | Robert Stanton: DO NOT have relevant financial relationships | Brett Kissela: No Answer | Dawn Kleindorfer: DO have relevant financial relationships ; Advisor:Bayer:Past (completed) | Heidi Sucharew: DO NOT have relevant financial relationships | Alexander Merkler: No Answer | Richa Sharma: DO NOT have relevant financial relationships | Felipe De Los Rios La Rosa: No Answer | Jason Mackey: No Answer | Simona Ferioli: No Answer | Eva Mistry: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Translational Sciences:Active (exists now) ; Research Funding (PI or named investigator):Patient Centered Outcomes Research Institute:Active (exists now) ; Research Funding (PI or named investigator):National Institutes of Health:Active (exists now) ; Consultant:SilverCreek Pharmaceuticals:Active (exists now) ; Consultant:RAPID AI:Past (completed) ; Consultant:AbbVie:Active (exists now)
Meeting Info:
Session Info:

Risk Factors and Prevention Posters II

Thursday, 02/06/2025 , 07:00PM - 07:30PM

Poster Abstract Session

More abstracts on this topic:
A Novel Echocardiography Risk Score Predicted Mortality In Patients With Heart Failure With Preserved Ejection Fraction.

Iwakura Katsuomi, Yoshio Yasumura, Hikoso Shungo, Okada Katsuki, Nakatani Daisaku, Sotomi Yohei, Sakata Yasushi, Tanaka Nobuaki, Okada Masato, Okamura Atsunori, Heitaro Watanabe, Seo Masahiro, Hayashi Takaharu, Yano Masamichi, Yamada Takahisa

10-Year Trends in Last Known Well to Arrival Time in Acute Ischemic Stroke Patients: 2014-2023

Ferrone Nicholas, Sanmartin Maria, O'hara Joseph, Jimenez Jean, Ferrone Sophia, Wang Jason, Katz Jeffrey, Sanelli Pina

More abstracts from these authors:
Large Vessel Occlusion Stroke in A Population: Prevalence, Presenting Characteristics, Treatment, and Mortality

Aziz Yasmin, Menzies Lauren, Wright Shea, Nobel Lisa, Stamm Brian, Delosrioslarosa Felipe, Slavin Sabreena, Walsh Kyle, Mistry Eva, Khatri Pooja, Kleindorfer Dawn, Sucharew Heidi, Kissela Brett, Robinson David, Stanton Robert, Ferioli Simona, Woo Daniel, Haverbusch Mary, Laporta Joseph, Wechsler Paul

Population-based Study of Stroke Recurrence in Overweight or Obese Patients: Considerations for Future Prevention Trials

Yahnke Ian, Demel Stacie, Mistry Eva, Coleman Elisheva, Jasne Adam, Slavin Sabreena, Walsh Kyle, Star Michael, Stanton Robert, Ljungberg Lovisa, Kamel Hooman, Sucharew Heidi, Haverbusch Mary, Kissela Brett, Broderick Joseph, Robinson David, Kleindorfer Dawn, Ferioli Simona, Mackey Jason, Woo Daniel, Delosrioslarosa Felipe

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)